ACCIÓ awards the Institute’s Innovation Department with the quality seal TECNIO and two VALUNI grants for technology transfer projects
An innovative programme from IRB Barcelona’s Innovation Department enables researchers to explore how to implement their entrepreneurial ideas
How do you make a successful move from academia to industry? In March, Albert Farré, Brand Manager at Novartis Oncology, told IRB Barcelona scientists who attended the “Building Bridges in your network” workshop how he did it. And he has some good advice for budding entrepreneurs.
On the occasion of the BIO-Europe Spring 2017 event in Barcelona, the newspaper “La Vanguardia” has published an article about the campaign to host the new headquarters of the London-based European Medicines Agency (EMA) after Brexit.
The article also includes a reference to the participation of IRB Barcelona’s Innovation Department in this three-day partnering conference for the biotechnology industry.
The 11th international partnering conference comes to Barcelona from 20 to 22 March.
19 young researchers at IRB Barcelona will also be attending the three-day conference.
BIO-Europe Spring is the premier springtime partnering conference for the biotechnology industry.
IDIBAPS and IRB Barcelona researchers show the effectiveness of a new strategy to achieved genetically modified viruses that infect only tumor cells, thus preserving healthy tissues.
It is an innovative approach that exploits the different expression profiles of certain proteins between tumor and healthy cells, thus allowing the virus to infect only the former.
IRB Barcelona starts a project with the long-term goal to achieve an injectable frataxin treatment able to reach the brain.
Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.
The patients’ associations Babel Family and ASOGAF in Granada provide the funding for the initial 18 months of this challenge.
The research collaboration will combine Merus’ Biclonics technology platform and unique cell and animal models at the Colorectal Cancer Laboratory led by Eduard Batlle to investigate the stroma.
Last year, CERCA, the Catalan Government institution that supervises, supports and facilitates the activities of research of research centres in Catalonia, set up a patent fund called Gínjol. This initiative aims to provide funding for knowledge transfer projects and to promote the regional economy.
According to CERCA Director Lluís Rovira, “the idea is not to increase the number of patents, but rather choose those that can really have a commercial impact, with subsequent profits.” Eleven scientific institutions contributed resources to the...
Patrick Aloy, ICREA researcher at IRB Barcelona, has told the programme 'L'Entrevista', broadcasted by “La Xarxa Televisió”, that research into Alzheimer’s disease is still unravelling the disease, how it starts and what would be a suitable approach to tackle it."
Because of the complexity of this condition, Aloy says, "we will not cure Alzheimer’s disease. We have to focus on halting its progression. The earlier we stop the development of this condition, the greater the improvement in the health of those who suffer from it."
"To halt its progression, we will be able to administer drugs when symptoms of the disease are detected, thereby...